|  Help  |  About  |  Contact Us

Publication : Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

First Author  Perreault N Year  2005
Journal  Genes Dev Volume  19
Issue  3 Pages  311-5
PubMed ID  15650110 Mgi Jnum  J:95893
Mgi Id  MGI:3527931 Doi  10.1101/gad.1260605
Citation  Perreault N, et al. (2005) Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon. Genes Dev 19(3):311-5
abstractText  Constitutive activation of the Wnt/APC/beta-catenin pathway is a frequent initiating event in gastrointestinal carcinogenesis. Mutations in the Adenomatous Polyposis Coli (APC) gene up-regulate Wnt signaling by stabilizing beta-catenin and causing activation of targets important in proliferation control. Here we show that loss of the mesenchymal transcription factor Foxl1 leads to a marked increase in tumor multiplicity in the colon of Apc(Min) mice. Apc(Min/+);Foxl1-/- mice also develop gastric tumors not observed in Apc(Min) mice. These effects are caused by earlier tumor initiation due to accelerated loss of heterozygosity (LOH) at the Apc locus. Foxl1 is the first mesenchymal Modifier of Min and plays a key role in gastrointestinal tumorigenesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

8 Bio Entities

Trail: Publication

0 Expression